isoproterenol has been researched along with adenosine kinase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berne, RM; Coleman, SD; Ely, SW; Matherne, GP | 1 |
| Kather, H | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Mi, Z | 1 |
3 other study(ies) available for isoproterenol and adenosine kinase
| Article | Year |
|---|---|
Inhibition of adenosine metabolism increases myocardial interstitial adenosine concentrations and coronary flow.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Animals; Coronary Circulation; Extracellular Space; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Myocardium; Perfusion; Tubercidin; Vascular Resistance | 1992 |
Pathways of purine metabolism in human adipocytes. Further evidence against a role of adenosine as an endogenous regulator of human fat cell function.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Adenosine Diphosphate; Adenosine Kinase; Adenosine Monophosphate; Adenosine Triphosphate; Adipose Tissue; Glycerophosphates; Humans; Hypoxanthine; Hypoxanthines; Inosine; Inosine Monophosphate; Isoproterenol; Lipolysis; Pentostatin; Purines; Tubercidin | 1990 |
Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth.
Topics: Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Adenylyl Cyclase Inhibitors; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Cell Division; Colforsin; Cyclic AMP; DNA; Fibroblasts; Isoproterenol; Male; Myocardium; Norepinephrine; Protein Biosynthesis; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley | 2001 |